ClinConnect ClinConnect Logo
Search / Trial NCT07018791

Art-Based Pain Assessment Tool in Patients With Temporomandibular Joint Disorders

Launched by KING ABDULAZIZ UNIVERSITY · Jun 11, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Temporomandibular Joint Disorders Artistic Pain Exploration (Ape) Visual Pain Expression Art Based Assessment Multisensory Pain Assessment Randomized Controlled Trial Pain Communication Patient Reported Outcomes Tmj Function

ClinConnect Summary

This clinical trial is studying a new way to help patients with jaw joint disorders, known as Temporomandibular Disorders (TMD). The researchers want to see if an art-based tool can improve how patients express and understand their pain. In this study, participants will be divided into two groups: one will receive standard care for their condition, while the other will use the art-based tool, which involves discussing their pain through guided conversations about chosen paintings. The goal is to determine if this method helps patients communicate their pain better, improves jaw function, and reduces anxiety more than standard care alone.

To participate, you need to be at least 18 years old and have early-stage TMD that doesn’t require surgery. If you qualify, you will fill out questionnaires about your pain and anxiety before and after two weeks, undergo a clinical exam, and, if in the intervention group, discuss your pain using artwork. There is no cost to join, and your medical information will be kept confidential. If you feel uncomfortable at any time during the study, support will be available. The trial is currently recruiting participants, so if you think you might qualify, this could be a great opportunity to gain a better understanding of your pain and improve your communication with healthcare providers.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults aged 18 years or older
  • Diagnosed with Temporomandibular Disorders (TMD) requiring conservative management only and classified as Wilkes' stage I or II
  • Able to understand and sign the informed consent form
  • Exclusion Criteria:
  • Patients requiring surgical intervention for TMD
  • Presence of severe mental illness, such as psychotic disorders or bipolar affective disorders
  • Regular use of narcotic (opioid) pain medications

About King Abdulaziz University

King Abdulaziz University (KAU) is a leading academic institution located in Jeddah, Saudi Arabia, renowned for its commitment to advancing medical research and innovation. As a prominent clinical trial sponsor, KAU leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving healthcare outcomes. The university fosters collaboration among multidisciplinary teams of researchers, clinicians, and industry partners, ensuring adherence to rigorous ethical standards and regulatory requirements. KAU is dedicated to enhancing scientific knowledge and translating research findings into practical applications that benefit patients and the broader community.

Locations

Jeddah, Makkah, Saudi Arabia

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported